HEADER TRANSFERASE 02-OCT-17 6EME OBSLTE 20-NOV-19 6EME 6I2H TITLE CRYSTAL STRUCTURE OF THE PROTEIN-KINASE A CATALYTIC SUBUNIT FROM TITLE 2 CRITECULUS GRISEUS IN COMPLEX WITH COMPOUNDS RKP182 AND RKP190 COMPND MOL_ID: 1; COMPND 2 MOLECULE: CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: PKA C-ALPHA; COMPND 5 EC: 2.7.11.11; COMPND 6 ENGINEERED: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: CAMP-DEPENDENT PROTEIN KINASE INHIBITOR; COMPND 9 CHAIN: D; COMPND 10 ENGINEERED: YES; COMPND 11 OTHER_DETAILS: PKI 5-22 WITH G17RBS MUTATION SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: CRICETULUS GRISEUS; SOURCE 3 ORGANISM_COMMON: CHINESE HAMSTER; SOURCE 4 ORGANISM_TAXID: 10029; SOURCE 5 ORGAN: OVARY; SOURCE 6 TISSUE: OVARY; SOURCE 7 GENE: PRKACA; SOURCE 8 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 10 EXPRESSION_SYSTEM_VARIANT: GOLD PLYSS AG; SOURCE 11 MOL_ID: 2; SOURCE 12 SYNTHETIC: YES; SOURCE 13 ORGANISM_SCIENTIFIC: CRICETULUS GRISEUS; SOURCE 14 ORGANISM_COMMON: CHINESE HAMSTER; SOURCE 15 ORGANISM_TAXID: 10029 KEYWDS COMPLEX, PEPTIDIC LIGAND, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR J.M.MUELLER,A.HEINE,G.KLEBE REVDAT 3 08-DEC-21 6EME 1 OBSLTE COMPND HETNAM HETSYN REVDAT 2 20-NOV-19 6EME 1 OBSLTE REVDAT 1 31-OCT-18 6EME 0 JRNL AUTH J.M.MUELLER,R.KIRSCHNER,A.HEINE,A.GEYER,G.KLEBE JRNL TITL CRYSTAL STRUCTURE OF THE PROTEIN-KINASE A CATALYTIC SUBUNIT JRNL TITL 2 FROM CRITECULUS GRISEUS IN COMPLEX WITH COMPOUNDS RKP182 AND JRNL TITL 3 RKP190 JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 1.68 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (1.10.1_2155: ???) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.68 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 45.31 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.370 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 53303 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.183 REMARK 3 R VALUE (WORKING SET) : 0.182 REMARK 3 FREE R VALUE : 0.202 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 2666 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 45.3292 - 4.4777 1.00 2864 151 0.1821 0.1966 REMARK 3 2 4.4777 - 3.5545 1.00 2748 145 0.1617 0.1702 REMARK 3 3 3.5545 - 3.1053 1.00 2701 142 0.1863 0.2099 REMARK 3 4 3.1053 - 2.8215 1.00 2703 142 0.1908 0.2307 REMARK 3 5 2.8215 - 2.6193 1.00 2679 141 0.1835 0.2310 REMARK 3 6 2.6193 - 2.4648 1.00 2667 141 0.1744 0.1946 REMARK 3 7 2.4648 - 2.3414 1.00 2659 140 0.1719 0.1719 REMARK 3 8 2.3414 - 2.2395 1.00 2664 140 0.1752 0.1747 REMARK 3 9 2.2395 - 2.1533 1.00 2655 140 0.1793 0.1961 REMARK 3 10 2.1533 - 2.0790 1.00 2643 139 0.1869 0.2014 REMARK 3 11 2.0790 - 2.0140 1.00 2652 139 0.1872 0.2044 REMARK 3 12 2.0140 - 1.9564 1.00 2627 139 0.1907 0.2205 REMARK 3 13 1.9564 - 1.9049 1.00 2664 140 0.1938 0.2067 REMARK 3 14 1.9049 - 1.8584 1.00 2626 138 0.1993 0.2438 REMARK 3 15 1.8584 - 1.8162 1.00 2653 140 0.2159 0.2632 REMARK 3 16 1.8162 - 1.7775 1.00 2617 137 0.2046 0.2243 REMARK 3 17 1.7775 - 1.7420 1.00 2641 139 0.1975 0.2302 REMARK 3 18 1.7420 - 1.7091 1.00 2619 138 0.2057 0.2164 REMARK 3 19 1.7091 - 1.6786 0.98 2555 135 0.2185 0.2448 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.150 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 19.300 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.007 3038 REMARK 3 ANGLE : 0.904 4130 REMARK 3 CHIRALITY : 0.052 440 REMARK 3 PLANARITY : 0.006 548 REMARK 3 DIHEDRAL : 13.732 1786 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 5 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: CHAIN 'A' AND (RESID -2 THROUGH 31 ) REMARK 3 ORIGIN FOR THE GROUP (A): 9.3763 -8.6183 -0.5417 REMARK 3 T TENSOR REMARK 3 T11: 0.2634 T22: 0.3068 REMARK 3 T33: 0.2410 T12: -0.0818 REMARK 3 T13: -0.0415 T23: 0.0325 REMARK 3 L TENSOR REMARK 3 L11: 0.2689 L22: 0.3121 REMARK 3 L33: 0.3203 L12: -0.2044 REMARK 3 L13: 0.1545 L23: 0.0846 REMARK 3 S TENSOR REMARK 3 S11: -0.0148 S12: -0.0493 S13: 0.1028 REMARK 3 S21: 0.1235 S22: 0.0025 S23: 0.1493 REMARK 3 S31: -0.2443 S32: -0.1255 S33: 0.0007 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: CHAIN 'A' AND (RESID 32 THROUGH 114 ) REMARK 3 ORIGIN FOR THE GROUP (A): 21.6080 -15.2323 -28.6439 REMARK 3 T TENSOR REMARK 3 T11: 0.2556 T22: 0.3686 REMARK 3 T33: 0.3392 T12: 0.0411 REMARK 3 T13: 0.0283 T23: 0.0552 REMARK 3 L TENSOR REMARK 3 L11: 0.3075 L22: 1.2947 REMARK 3 L33: 0.2047 L12: 0.1344 REMARK 3 L13: -0.1407 L23: 0.0587 REMARK 3 S TENSOR REMARK 3 S11: 0.0778 S12: 0.0665 S13: -0.0303 REMARK 3 S21: -0.2417 S22: -0.0825 S23: -0.3425 REMARK 3 S31: 0.1412 S32: 0.3063 S33: -0.0000 REMARK 3 TLS GROUP : 3 REMARK 3 SELECTION: CHAIN 'A' AND (RESID 115 THROUGH 350 ) REMARK 3 ORIGIN FOR THE GROUP (A): 2.9006 -18.0140 -19.0530 REMARK 3 T TENSOR REMARK 3 T11: 0.1837 T22: 0.1755 REMARK 3 T33: 0.1611 T12: 0.0103 REMARK 3 T13: -0.0039 T23: 0.0122 REMARK 3 L TENSOR REMARK 3 L11: 0.9688 L22: 1.2367 REMARK 3 L33: 0.4825 L12: 0.1581 REMARK 3 L13: -0.1665 L23: -0.0013 REMARK 3 S TENSOR REMARK 3 S11: 0.0160 S12: 0.0322 S13: 0.0068 REMARK 3 S21: -0.0222 S22: -0.0677 S23: -0.0239 REMARK 3 S31: 0.0326 S32: 0.0896 S33: -0.0002 REMARK 3 TLS GROUP : 4 REMARK 3 SELECTION: CHAIN 'D' AND (RESID 8 THROUGH 15 ) REMARK 3 ORIGIN FOR THE GROUP (A): -11.9457 -30.5910 -28.6619 REMARK 3 T TENSOR REMARK 3 T11: 0.2938 T22: 0.2783 REMARK 3 T33: 0.3205 T12: 0.0360 REMARK 3 T13: -0.0261 T23: -0.0886 REMARK 3 L TENSOR REMARK 3 L11: 0.0241 L22: 0.0173 REMARK 3 L33: 0.0182 L12: 0.0172 REMARK 3 L13: 0.0002 L23: 0.0008 REMARK 3 S TENSOR REMARK 3 S11: -0.0492 S12: 0.1209 S13: -0.2279 REMARK 3 S21: -0.1403 S22: -0.0262 S23: 0.1974 REMARK 3 S31: 0.1530 S32: 0.0217 S33: -0.0000 REMARK 3 TLS GROUP : 5 REMARK 3 SELECTION: CHAIN 'D' AND (RESID 16 THROUGH 25 ) REMARK 3 ORIGIN FOR THE GROUP (A): -1.3723 -21.9580 -32.1034 REMARK 3 T TENSOR REMARK 3 T11: 0.3428 T22: 0.2779 REMARK 3 T33: 0.1773 T12: 0.0332 REMARK 3 T13: 0.0333 T23: -0.0086 REMARK 3 L TENSOR REMARK 3 L11: 0.1631 L22: 0.5072 REMARK 3 L33: 0.0381 L12: -0.0654 REMARK 3 L13: 0.0727 L23: 0.0067 REMARK 3 S TENSOR REMARK 3 S11: 0.2055 S12: 0.3367 S13: -0.0374 REMARK 3 S21: -0.3361 S22: -0.1658 S23: -0.1908 REMARK 3 S31: 0.0840 S32: -0.0069 S33: -0.0009 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6EME COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 5 REMARK 5 THE PEPTIDIC COMPOUND CONTAINS AN ASPARTATE (INSTEAD OF AN REMARK 5 ASPARAGINE) CLOSE TO THE C-TERMINUS. REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 03-OCT-17. REMARK 100 THE DEPOSITION ID IS D_1200006861. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 22-JUN-17 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.9 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : PETRA III, EMBL C/O DESY REMARK 200 BEAMLINE : P13 (MX1) REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.88559 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M-F REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XDS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 53307 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.680 REMARK 200 RESOLUTION RANGE LOW (A) : 45.313 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 7.390 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.06600 REMARK 200 FOR THE DATA SET : 15.1600 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.68 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.78 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.2 REMARK 200 DATA REDUNDANCY IN SHELL : 7.28 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.49800 REMARK 200 FOR SHELL : 3.050 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 57.07 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.86 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 100 MM MES-BIS-TRIS, 75 MM LITHIUM REMARK 280 CHLORIDE, 1 MM DTT, 0.1 MM SODIUM EDTA, 0.25 MM MEGA 8, 0.7 MM REMARK 280 PEPTIDIC LIGAND, 5 MM RKP190, 20% V/V METHANOL/WATER IN REMARK 280 RESERVOIR, PH 6.9, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE REMARK 280 277.15K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 29.23500 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 54.80600 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 35.84900 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 54.80600 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 29.23500 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 35.84900 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2030 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 16660 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -8.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ASN A 2 CG OD1 ND2 REMARK 470 LYS A 16 NZ REMARK 470 LYS A 21 CD CE NZ REMARK 470 GLU A 24 CG CD OE1 OE2 REMARK 470 GLU A 25 CD OE1 OE2 REMARK 470 LYS A 28 CG CD CE NZ REMARK 470 LYS A 29 NZ REMARK 470 SER A 32 OG REMARK 470 SER A 34 OG REMARK 470 ARG A 45 CG CD NE CZ NH1 NH2 REMARK 470 ILE A 46 CG1 CD1 REMARK 470 ARG A 56 NE CZ NH1 NH2 REMARK 470 LYS A 61 CE NZ REMARK 470 GLU A 64 CG CD OE1 OE2 REMARK 470 THR A 65 OG1 CG2 REMARK 470 LYS A 78 CD CE NZ REMARK 470 LYS A 81 CG CD CE NZ REMARK 470 LEU A 82 CD1 CD2 REMARK 470 LYS A 83 CG CD CE NZ REMARK 470 ILE A 135 CG1 CG2 CD1 REMARK 470 GLN A 176 CG CD OE1 NE2 REMARK 470 VAL A 191 CG1 CG2 REMARK 470 LYS A 192 CG CD CE NZ REMARK 470 LYS A 217 NZ REMARK 470 ILE A 244 CG2 CD1 REMARK 470 GLN A 245 CD OE1 NE2 REMARK 470 LYS A 254 CG CD CE NZ REMARK 470 ARG A 256 CG CD NE CZ NH1 NH2 REMARK 470 LEU A 277 CG CD1 CD2 REMARK 470 LYS A 285 CG CD CE NZ REMARK 470 ASN A 286 CG OD1 ND2 REMARK 470 LYS A 295 NZ REMARK 470 ILE A 303 CD1 REMARK 470 GLU A 311 CG CD OE1 OE2 REMARK 470 LYS A 317 CG CD CE NZ REMARK 470 PHE A 318 CG CD1 CD2 CE1 CE2 CZ REMARK 470 LYS A 319 CG CD CE NZ REMARK 470 GLU A 331 CG CD OE1 OE2 REMARK 470 GLU A 333 CG CD OE1 OE2 REMARK 470 GLU A 334 CG CD OE1 OE2 REMARK 470 ILE A 335 CG1 CG2 CD1 REMARK 470 ARG A 336 CG CD NE CZ NH1 NH2 REMARK 470 ILE A 339 CG1 CG2 CD1 REMARK 470 ASN A 340 OD1 ND2 REMARK 470 LYS A 342 CD CE NZ REMARK 470 LYS A 345 CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 144 NE - CZ - NH2 ANGL. DEV. = 3.0 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA A 38 -176.63 -175.12 REMARK 500 ASP A 166 44.07 -144.79 REMARK 500 LEU A 273 48.95 -88.51 REMARK 500 REMARK 500 REMARK: NULL REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 AO8 A 401 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue AO8 A 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CL D 102 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for Mono-Saccharide RIP D 101 bound REMARK 800 to SER D 20 DBREF 6EME A 0 350 UNP P25321 KAPCA_CRIGR 1 351 DBREF 6EME D 8 25 PDB 6EME 6EME 8 25 SEQADV 6EME GLY A -2 UNP P25321 EXPRESSION TAG SEQADV 6EME HIS A -1 UNP P25321 EXPRESSION TAG SEQRES 1 A 353 GLY HIS MET GLY ASN ALA ALA ALA ALA LYS LYS GLY SEP SEQRES 2 A 353 GLU GLN GLU SER VAL LYS GLU PHE LEU ALA LYS ALA LYS SEQRES 3 A 353 GLU GLU PHE LEU LYS LYS TRP GLU SER PRO SER GLN ASN SEQRES 4 A 353 THR ALA GLN LEU ASP HIS PHE ASP ARG ILE LYS THR LEU SEQRES 5 A 353 GLY THR GLY SER PHE GLY ARG VAL MET LEU VAL LYS HIS SEQRES 6 A 353 LYS GLU THR GLY ASN HIS TYR ALA MET LYS ILE LEU ASP SEQRES 7 A 353 LYS GLN LYS VAL VAL LYS LEU LYS GLN ILE GLU HIS THR SEQRES 8 A 353 LEU ASN GLU LYS ARG ILE LEU GLN ALA VAL ASN PHE PRO SEQRES 9 A 353 PHE LEU VAL LYS LEU GLU PHE SER PHE LYS ASP ASN SER SEQRES 10 A 353 ASN LEU TYR MET VAL MET GLU TYR VAL PRO GLY GLY GLU SEQRES 11 A 353 MET PHE SER HIS LEU ARG ARG ILE GLY ARG PHE SEP GLU SEQRES 12 A 353 PRO HIS ALA ARG PHE TYR ALA ALA GLN ILE VAL LEU THR SEQRES 13 A 353 PHE GLU TYR LEU HIS SER LEU ASP LEU ILE TYR ARG ASP SEQRES 14 A 353 LEU LYS PRO GLU ASN LEU LEU ILE ASP GLN GLN GLY TYR SEQRES 15 A 353 ILE GLN VAL THR ASP PHE GLY PHE ALA LYS ARG VAL LYS SEQRES 16 A 353 GLY ARG THR TRP TPO LEU CYS GLY THR PRO GLU TYR LEU SEQRES 17 A 353 ALA PRO GLU ILE ILE LEU SER LYS GLY TYR ASN LYS ALA SEQRES 18 A 353 VAL ASP TRP TRP ALA LEU GLY VAL LEU ILE TYR GLU MET SEQRES 19 A 353 ALA ALA GLY TYR PRO PRO PHE PHE ALA ASP GLN PRO ILE SEQRES 20 A 353 GLN ILE TYR GLU LYS ILE VAL SER GLY LYS VAL ARG PHE SEQRES 21 A 353 PRO SER HIS PHE SER SER ASP LEU LYS ASP LEU LEU ARG SEQRES 22 A 353 ASN LEU LEU GLN VAL ASP LEU THR LYS ARG PHE GLY ASN SEQRES 23 A 353 LEU LYS ASN GLY VAL ASN ASP ILE LYS ASN HIS LYS TRP SEQRES 24 A 353 PHE ALA THR THR ASP TRP ILE ALA ILE TYR GLN ARG LYS SEQRES 25 A 353 VAL GLU ALA PRO PHE ILE PRO LYS PHE LYS GLY PRO GLY SEQRES 26 A 353 ASP THR SER ASN PHE ASP ASP TYR GLU GLU GLU GLU ILE SEQRES 27 A 353 ARG VAL SEP ILE ASN GLU LYS CYS GLY LYS GLU PHE THR SEQRES 28 A 353 GLU PHE SEQRES 1 D 18 THR THR TYR ALA ASP PHE ILE ALA SER GLY ARG THR SER SEQRES 2 D 18 ARG ARG ASN ALA ILE MODRES 6EME SEP A 10 SER MODIFIED RESIDUE MODRES 6EME SEP A 139 SER MODIFIED RESIDUE MODRES 6EME TPO A 197 THR MODIFIED RESIDUE MODRES 6EME SEP A 338 SER MODIFIED RESIDUE HET SEP A 10 14 HET SEP A 139 28 HET TPO A 197 17 HET SEP A 338 14 HET AO8 A 401 42 HET RIP D 101 18 HET CL D 102 1 HETNAM SEP PHOSPHOSERINE HETNAM TPO PHOSPHOTHREONINE HETNAM AO8 [2-[[2-(ISOQUINOLIN-5-YLSULFONYLAMINO) HETNAM 2 AO8 ETHYLAMINO]METHYL]PHENYL]BORONIC ACID HETNAM RIP BETA-D-RIBOPYRANOSE HETNAM CL CHLORIDE ION HETSYN SEP PHOSPHONOSERINE HETSYN TPO PHOSPHONOTHREONINE HETSYN RIP BETA-D-RIBOSE; D-RIBOSE; RIBOSE; RIBOSE(PYRANOSE FORM) FORMUL 1 SEP 3(C3 H8 N O6 P) FORMUL 1 TPO C4 H10 N O6 P FORMUL 3 AO8 C18 H20 B N3 O4 S FORMUL 4 RIP C5 H10 O5 FORMUL 5 CL CL 1- FORMUL 6 HOH *196(H2 O) HELIX 1 AA1 GLY A 1 SER A 32 1 32 HELIX 2 AA2 GLN A 39 ASP A 41 5 3 HELIX 3 AA3 LYS A 76 LEU A 82 1 7 HELIX 4 AA4 GLN A 84 VAL A 98 1 15 HELIX 5 AA5 GLU A 127 GLY A 136 1 10 HELIX 6 AA6 SEP A 139 LEU A 160 1 22 HELIX 7 AA7 LYS A 168 GLU A 170 5 3 HELIX 8 AA8 THR A 201 LEU A 205 5 5 HELIX 9 AA9 ALA A 206 LEU A 211 1 6 HELIX 10 AB1 LYS A 217 GLY A 234 1 18 HELIX 11 AB2 GLN A 242 GLY A 253 1 12 HELIX 12 AB3 SER A 262 LEU A 273 1 12 HELIX 13 AB4 VAL A 288 ASN A 293 1 6 HELIX 14 AB5 HIS A 294 ALA A 298 5 5 HELIX 15 AB6 ASP A 301 GLN A 307 1 7 HELIX 16 AB7 GLY A 344 THR A 348 5 5 HELIX 17 AB8 THR D 9 SER D 16 1 8 SHEET 1 AA1 5 PHE A 43 THR A 51 0 SHEET 2 AA1 5 GLY A 55 HIS A 62 -1 O LEU A 59 N LYS A 47 SHEET 3 AA1 5 HIS A 68 ASP A 75 -1 O ILE A 73 N ARG A 56 SHEET 4 AA1 5 ASN A 115 GLU A 121 -1 O MET A 120 N ALA A 70 SHEET 5 AA1 5 LEU A 106 LYS A 111 -1 N PHE A 108 O VAL A 119 SHEET 1 AA2 2 LEU A 162 ILE A 163 0 SHEET 2 AA2 2 LYS A 189 ARG A 190 -1 O LYS A 189 N ILE A 163 SHEET 1 AA3 2 LEU A 172 ILE A 174 0 SHEET 2 AA3 2 ILE A 180 VAL A 182 -1 O GLN A 181 N LEU A 173 LINK C GLY A 9 N SEP A 10 1555 1555 1.33 LINK C SEP A 10 N GLU A 11 1555 1555 1.34 LINK C PHE A 138 N ASEP A 139 1555 1555 1.34 LINK C PHE A 138 N BSEP A 139 1555 1555 1.33 LINK C ASEP A 139 N GLU A 140 1555 1555 1.33 LINK C BSEP A 139 N GLU A 140 1555 1555 1.33 LINK C TRP A 196 N TPO A 197 1555 1555 1.33 LINK C TPO A 197 N LEU A 198 1555 1555 1.33 LINK C VAL A 337 N SEP A 338 1555 1555 1.33 LINK C SEP A 338 N ILE A 339 1555 1555 1.33 LINK OG SER D 20 C1 RIP D 101 1555 1555 1.37 SITE 1 AC1 15 GLY A 50 VAL A 57 ALA A 70 MET A 120 SITE 2 AC1 15 GLU A 121 TYR A 122 VAL A 123 GLU A 127 SITE 3 AC1 15 GLU A 170 ASN A 171 LEU A 173 THR A 183 SITE 4 AC1 15 ASP A 184 PHE A 327 ARG D 22 SITE 1 AC2 3 ARG A 194 SER D 20 ARG D 21 SITE 1 AC3 5 LYS A 192 GLY A 193 ARG A 194 GLY D 17 SITE 2 AC3 5 SER D 20 CRYST1 58.470 71.698 109.612 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.017103 0.000000 0.000000 0.00000 SCALE2 0.000000 0.013947 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009123 0.00000